Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
COVID-19
•
General Rheumatology
•
Infectious Disease
How do you counsel immunosuppressed patients regarding a third Covid vaccination dose if they have had 2 doses of mRNA vaccine and either pre or post vaccine Covid infection?
Related Questions
In a patient with a history of seropositive erosive RA who has undergone treatment for a periprosthetic joint infection and currently has an antibiotic spacer in place with clinical improvement, what is the appropriate timing and strategy for restarting DMARDs and/or biologic therapy to balance infection risk with RA disease control?
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?
Do you regularly recommend an immunological workup for patients with suspected immunodeficiency or defer to immunology?
Do you have to extend treatment for acute Lyme disease if a patient is on high dose steroids for another indication?
What are your vaccine recommendations while patients are on biologics?
Can inflammatory arthritis develop in patients with a history of chronic hepatitis B?
In a patient with negative Hep B surface Ag, Hep B surface antibody+, and Hep B core antibody+ serologies, do you initiate antiviral prophylaxis (e.g. entecavir) prior to starting rituximab?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
